Ongoing research aims to develop new formulations and combination therapies that mitigate the toxic effects of doxorubicin. Investigations into the use of antioxidant supplements, alternative dosing schedules, and nanotechnology-based delivery systems are promising avenues. Personalized medicine approaches that tailor treatment based on a patient's genetic profile are also being explored.
